Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vecuronium Priming to Reduce Opioid-Induced Cough During Anesthesia Induction
ChiCTR-IPR-16007827Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vecuronium in cough (4 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Incidence and severity of opioid-induced coughing, Blood pressure and 2 more. Planned start Feb 2016; status: not yet recruiting.
02
Drugs
vecuronium
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR-IPR-16007827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16007827.